PMC:7600245 / 29004-29206
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T121 | 181-187 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T266 | 70-71 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T267 | 181-187 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T408 | 148-157 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T49 | 134-144 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T215 | 0-202 | Sentence | denotes | Ritonavir does not only provide an additive effective, but it is also a pharmacokinetic booster, i.e., it inhibits the CYP3A-mediated metabolism of lopinavir and thus increases its plasma level [83,84]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 811 | 119-124 | Gene | denotes | CYP3A | Gene:1576 |
| 821 | 0-9 | Chemical | denotes | Ritonavir | MESH:D019438 |
| 822 | 148-157 | Chemical | denotes | lopinavir | MESH:D061466 |